A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/01/2002	US6458837 Lipophilic diesters of chelating agents
10/01/2002	US6458836 Treatment of ocular hypertension and glaucoma
10/01/2002	US6458835 Using 4-(((cyanoimino)-((1,2,2-trimethylpropyl)amino) methyl)amino)benzonitrile
10/01/2002	US6458833 Organometallic complex
10/01/2002	US6458831 Matairesinol and (-)- wikstromol phenols together with or associated with therapeutically acceptable additives are useful as antioxidants and as free radical scavengers
10/01/2002	US6458830 The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia.
10/01/2002	US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto
10/01/2002	US6458827 Adjustent of conformation equilibrium; active materials
10/01/2002	US6458825 Eukaryotic cells contain multiple proteolytic systems, including lysosomal proteases, calpains, atp-ubiquitin-proteasome dependent pathway, and an
10/01/2002	US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002	US6458820 Nervous system disorders the use of pramipexole as a neuroprotective agent.
10/01/2002	US6458819 Thiazolium compounds and treatments of disorders associated with protein aging
10/01/2002	US6458818 Pharmaceutical composition
10/01/2002	US6458816 Anticancer agents
10/01/2002	US6458814 Vitronectin receptor antagonists and are useful in the treatment of osteoporosis: treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor,
10/01/2002	US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002	US6458812 Muscarinic antagonists
10/01/2002	US6458811 Benzothiophenes formulations containing same and methods
10/01/2002	US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002	US6458809 Desmethylastemizole, 6-hydroxydesmethylastemizole and norastemizole; antihistamines; side effect reduction
10/01/2002	US6458808 Pharmaceutical composition for the treatment of cognitive cerebrovascular disease
10/01/2002	US6458807 Methods for treating vascular dementia
10/01/2002	US6458806 Aryl alkenamides derivatives as MCP-1 antagonists
10/01/2002	US6458805 Antagonists; especially sodium salts
10/01/2002	US6458804 Methods for the treatment of central nervous system disorders in certain patient groups
10/01/2002	US6458801 Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
10/01/2002	US6458800 1,2-annelated quinoline derivatives
10/01/2002	US6458799 Deazaguanine analog, preparation thereof and use thereof
10/01/2002	US6458797 Methods for remodeling neuronal and cardiovascular pathways
10/01/2002	US6458796 Method of treating cardiovascular disorders, thromboembolic disorders and ischaemias, and urogenital system disorders, comprising administering to mammals
10/01/2002	US6458795 Method and composition for treatment of irritable bowel disease
10/01/2002	US6458794 Potassium channel inhibitors
10/01/2002	US6458793 Heterocyclic derivatives which inhibit factor Xa
10/01/2002	US6458791 Methods of treating muscle spasms using N-desmethylzopiclone
10/01/2002	US6458790 Substituted piperidines as melanocortin receptor agonists
10/01/2002	US6458788 4-hydroxycinnoline-3-carboxyamides as antiviral agents
10/01/2002	US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002	US6458785 Aids therapy
10/01/2002	US6458782 Treatments of diabetes and complications of diabetes.
10/01/2002	US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf).
10/01/2002	US6458777 Methods and compositions for treating and preventing mucositis
10/01/2002	US6458776 Inflammatory bowel disease
10/01/2002	US6458775 NAALADase inhibitors useful as pharmaceutical compounds and compositions
10/01/2002	US6458773 Nucleoside with anti-hepatitis B virus activity
10/01/2002	US6458771 Series of ketolide antibacterials in the macrolide family, drugs and intermediates, erythromycin analogues useful in the treatment of bacterial and protozoal infections and in the treatment of gastric motility
10/01/2002	US6458770 Parenteral formulations comprising carbamazepine or its derivatives
10/01/2002	US6458768 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
10/01/2002	US6458766 A pharmaceutically acceptable salt or derivatives thereof, useful for preventing or treating viral and microbial infections, of oligopeotides
10/01/2002	US6458760 Comprising administering to said patient a therapeutically effective amount of a compound which is a specific inhibitor of either cathepsin b or cathepsin l, but which is not as effective inhibitor of calpain
10/01/2002	US6458580 Fungal sulphur source and method of using the same
10/01/2002	US6458567 Hepatitis C Virus ribozymes
10/01/2002	US6458529 Assays for promoter operability in central nervous system cells
10/01/2002	US6458527 Using synthetic or recombinant polypeptides as gag antigen; diagnosis of human immunodeficiency virus
10/01/2002	US6458392 Using coffee bean extract
10/01/2002	US6458389 Microgranules containing cisplatin
10/01/2002	US6458386 Medicaments based on polymers composed of methacrylamide-modified gelatin
10/01/2002	US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002	US6458376 Nonaqueous fluorinated drug delivery suspensions
10/01/2002	US6458374 Methods and compositions for treating chronic disorders using optically pure (+)-bupropion
10/01/2002	US6458373 Emulsion vehicle for poorly soluble drugs
10/01/2002	US6458369 Composition comprising tumor cells and extracts and method of using thereof
10/01/2002	US6458362 Recombinant VP2 parvoviral pseudo-particles encoding CTL or T-helper cell epitopes
10/01/2002	US6458351 Yeast extracts
10/01/2002	US6458346 Broad spectrum microbicidal and spermicidal compositions, devices, and methods
10/01/2002	US6458338 Amino acid stabilized medicinal aerosol formulations
10/01/2002	US6458147 Compositions, systems, and methods for arresting or controlling bleeding or fluid leakage in body tissue
10/01/2002	US6458026 Transfection complex comprising a first component comprising one or more lipids, a second component comprising an oligolysine linked via a peptide bond to an integrin-binding peptide, and a third component comprising a nucleic acid
10/01/2002	CA2272719C Apo b-secretion/mtp inhibitory amides
10/01/2002	CA2248047C Antagonism of endothelin actions
10/01/2002	CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists
10/01/2002	CA2241845C 4,5-dihydronaphth¬1,2-c\|isoxazoles and derivatives thereof having cns activity
10/01/2002	CA2235943C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
10/01/2002	CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002	CA2210258C Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/01/2002	CA2209735C Treatment of attention-deficit/hyperactivity disorder
10/01/2002	CA2209018C Sulfonamides and their use
10/01/2002	CA2203850C Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists
10/01/2002	CA2174550C Suspension of loteprednol etabonate
10/01/2002	CA2145411C Viscous liquid xylitol compositions and process for preparing the same
10/01/2002	CA2137731C Disinfectant for preventing coccidiosis in animals
10/01/2002	CA2124284C Drug for neuroprotection
10/01/2002	CA2123909C New combination of formoterol and budesonide
10/01/2002	CA2106312C Percutaneous anaesthesia
10/01/2002	CA2103546C Modified factor vii
10/01/2002	CA2089769C Heterocyclic compounds and their preparation and use
10/01/2002	CA2081911C Method and composition for treating psoriasis
10/01/2002	CA2071520C Elimination of activated lymphocytes
10/01/2002	CA2065571C Phosphorylated lipid based dietetic compositions and their use in the improvement of vision problems
10/01/2002	CA2065104C Erucyl, brassidyl and nervonyl derivatives
10/01/2002	CA2063926C Imidazopyridine
10/01/2002	CA2059708C Indole derivatives
10/01/2002	CA2057714C Progestagen-only contraceptive
09/2002
09/30/2002	CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors
09/30/2002	CA2379203A1 Food with extended energy release
09/30/2002	CA2343455A1 Control of cell growth by altering cell membrane potentials
09/30/2002	CA2342472A1 Ram having dynamically switchable addressing modes
09/30/2002	CA2342470A1 Method for treatment of cancer and benzimidazole compositions for use therein
09/27/2002	CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/26/2002	WO2002075304A1 Method of examining allergic disease
09/26/2002	WO2002075302A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal

1 ... 5695 5696 5697 5698 5699 5700 5701 5702 5703 5704 5705 5706 5707 5708 5709 5710 5711 5712 5713 5714 5715 ... 7860